:::

詳目顯示

回上一頁
題名:卵巢過度刺激徵候群
書刊名:護理雜誌
作者:翁敏雪周弘傑詹景全李從業
作者(外文):Weng, Min-hsuehChou, Hung-chiehChan, Chying-chyuanLee, Tsorng-yeh
出版日期:2003
卷期:50:1
頁次:頁98-102
主題關鍵詞:卵巢過度刺激徵候群人工生殖科技管通透性第三腔室Ovarian hyperstimulation syndromeAssisted conceptionCapillary permeabilityThird space
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(2) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:2
  • 共同引用共同引用:0
  • 點閱點閱:32
     使用人工生殖科技懷孕易產生卵巢過度刺激徵候群,對強烈追求子賜的婦女而言,是很大的身心壓力。注射人類絨毛膜性腺激素後可能會使得血液中血管上皮因子的濃度上升,此因子會使血管通透性增加,血管內的液體跑至第三腔室,而造成卵巢過度刺激徵候群令人不適的徵狀。會產生卵巢過度刺激徵候群的危險因子包括:對人類絨毛膜性腺激素的敏感度、年紀、使用人類絨毛膜性腺激素做為驅動排卵者、體外受精次數、過敏史。雖然發生卵巢過度刺激徵候群並沒有比較好的治療方式,但是依病情程度的不同予以不同的治療,才能對症狀的緩解及減輕不適上有所助益。本文整合相關文獻資料,提供徵候群的概述並介紹治療方式,希望提昇臨床工作人員對此徵候群之了解,以做為日後護理照護之參考。
     Assisted conception in patients with ovarian hyperstimulation syndrome is a large stress. Serum vascular endothelial growth factor concentrations rise in HCG administration. Vascular endothelial growth factor is an endothelial cell mitogen with angiogenic properties and is a mediator of ovarian hyperstimulation syndrome. The defect in ovarian hyperstimulation syndrome is altered capillary permeability, which results in increased capillary leakage of fluid into the third space. The risk factors associated with ovarian hyperstimulation syndrome are: a sensitive ovarian response to ovulation induction agents, the age of the patient, the administration of human chorionic gonadotrophin to trigger the ovulatory process, the frequency of assisted conception, patient's allergic history. The treatment is supportive, aiming at limiting and alleviating symptoms.
期刊論文
1.Enskog, A.、Nilsson, L.、Henriksson, M.、Unander, M.、Nilsson, L.、Brannstrom, M.(1999)。Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization。Fertility and Sterility,71(5),808-814。  new window
2.Bernstein, J.、Brill, M.、Levin, S.、Seibel, M.(1992)。Coping with infertility: A new nursing perspective。NAACOG's Clinical Issues in Perinatal and Women's Health Nursing,3(2),335-342。  new window
3.Artini, P. G.、Fasciani, A.、Monti, M.、Luidi, S.、D'Ambrogio, G.、Genazzani, A. R.(1998)。Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in fertilization program。Fertility and Sterility,70(3),560-564。  new window
4.Agrawal, R.、Tan, S. L.、Wild, S.、Sladkevicius, P.、Engmann, L.、Payne, N.、Bekir, J.、Campbell, S.、Conway, G.、Jacobs, H.(1999)。Serum vascular endothelial growth factor concentrations in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome。Fertility and Sterility,71(2),287-293。  new window
5.Agrawal, R.、Conway, G.、Sladkevicius, P.、Tan, S. L.、Engmann, L.、Payne, N.、Bekir, J.、Campbell, S.、Jacobs, H.(1998)。Serum vascular endothelial growth factor and doppler blood flow velocities in in vitro fertilization; Relevance to ovarian hyperstimulation syndrome and polycystin ovaries。Fertility and Sterility,70(4),651-658。  new window
6.Abramov, Y.、Naparstek, Y.、Elchalal, U.、Lewin, A.、Schecbter, H.、Schenker, J. G.(1999)。Plasma immunoglobulins in patients with severe ovarian hyperstimulation syndrome。Fertility and Sterility,71(1),102-105。  new window
7.Hahn, S. J.、Butkowski, C. R.、Capper, L. L.(1994)。Ovarian hyperstimulation syndrome: Protocols for nursing care。Journal of Obstetrics and Gynaecology Nursing,23(3),217-226。  new window
8.Enskog, A.、Nilsson, L.、Brannstrom, M.(2001)。Low peripheral blood levels of the immunosuppressive cytokine interleukin 10 at the start of gonadotrophin stimulation indicates increased risk for development of ovarian hyperstiraulation syndrome。Journal of Reproductive Immunology,49(1),71-85。  new window
9.Dolde, N.、Destefani, A.、Gessi, A.、Grosse, D.、Ferrari, A.(1999)。Human albumin enhances expression of vascular endothelial growth factor in cultured human luteinizing granulosa cells: Importance in ovarian hyperstimulation syndrome。Human Reproduction,14(5),1157-1159。  new window
10.Brinsden, P. R.、Wada, I.、Tan, S. L.、Balen, A.、Jacobs, H. S.(1995)。Diagnosis, prevention and management of ovarian hyperstimulation syndrome。British Journal of Obstetrics and Gynaecology,102,767-772。  new window
11.Pellicer, A.、Albert, C.、Mercader, A.、Bonilla-Musoles, F.、Remohi, J.、Simon, C.(1999)。The pathogenesis of ovarian hyperstimulation syndrome: in vitro studies investigating the role of interleukin-1β, interleukin-6, and vascular endothelial growth factor。Fertility and Sterility,71(3),482-489。  new window
12.Orvieto, R.、Ben-Rafael, Z.(1998)。Role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome。Human Reproduction,13(12),3306-3309。  new window
13.Myrianthefs, P.、Ladakis, C.、Lappas, V.、Pactitis, S.、Carouzou, A.、Fildisis, G.、Baltopoulos, G.(2000)。Ovarian hyperstimulation syndrome (OHSS): Diagnosis and management。Intensive Care Medicine,26(5),631-634。  new window
14.Mathur, R. S.、Akande, A.、Keay, S.、Hunt, L. P.、Julian, J.(2000)。Distinction between early and late ovarian hyperstimulation syndrome。Fertility and Sterility,73(5),901-907。  new window
15.Levin, E. R.、Rosen, G. F.、Cassidenti, D. L.、Yee, B.、Meldrum, D.(1998)。Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome。Journal of Clinical Investigation,102(11),1978-1985。  new window
16.Whelan, J. G.、Vlahos, N. F.(2000)。The ovarian hyperstimulation syndrome。Fertility and Sterility,75(5),883-896。  new window
17.Senger, D. R.、Galli, S. J.、Dvorak, A. M.、Perruzzi, C. A.、Dvorak, H. F.(1983)。Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid。Science,219(4587),983-985。  new window
18.Raziel, A.、Friedler, S.、Schachter, M.、Strassburger, D.、Bukovsky, I.、Ron-EI, R.(1998)。Transvaginal drainage of ascetes as an alternative to abdominal paracentesis in patients with sivere ovarian hyperstimulation syndrome, obesity, and generalized edema。Fertility and Sterility,69(4),780-783。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE